scispace - formally typeset
H

Holly Delgado

Researcher at University of South Florida

Publications -  8
Citations -  6580

Holly Delgado is an academic researcher from University of South Florida. The author has contributed to research in topics: Age of onset & Randomized controlled trial. The author has an hindex of 8, co-authored 8 publications receiving 4986 citations.

Papers
More filters
Journal ArticleDOI

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Christopher G. Goetz, +87 more
- 15 Nov 2008 - 
TL;DR: The combined clinimetric results of this study support the validity of the MDS‐UPDRS for rating PD.
Journal ArticleDOI

The Parkinson Progression Marker Initiative (PPMI)

TL;DR: The Parkinson Progression Marker Initiative (PPMI) is a comprehensive observational, international, multi-center study designed to identify PD progression biomarkers both to improve understanding of disease etiology and course and to provide crucial tools to enhance the likelihood of success of PD modifying therapeutic trials.
Journal ArticleDOI

Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease

Tatiana Foroud, +98 more
- 11 Mar 2003 - 
TL;DR: Mutations in the parkin gene occur among individuals with PD with an older age at onset (≥60 years) who have a positive family history of the disease, and the clinical findings of parkin-positive individuals are remarkably similar to those without mutations.
Journal ArticleDOI

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

Karl Kieburtz, +123 more
- 02 Jan 2007 - 
TL;DR: Coenzyme Q10 and GPI-1485 may warrant further study in Parkinson disease, although the data are inconsistent, and additional factors should be considered in the selection of agents for Phase III studies.
Journal ArticleDOI

Significant Linkage of Parkinson Disease to Chromosome 2q36-37

Nathan Pankratz, +99 more
TL;DR: This work has expanded the sample to include 150 families meeting the strictest diagnostic definition of verified PD, and performs analyses using only those pedigrees with the strongest family history of PD, which strongly suggests that variation in a gene on chromosome 2q36-37 contributes to PD susceptibility.